Terms: = Lymphoma AND CDX2, CDX3, 1045, ENSG00000165556, Q99626 AND Prognosis
12 results:
1. Prognostic impact of peripheral natural killer cells in primary central nervous system lymphoma.
Lin Z; Ma J; Ma Y; Li Q; Kang H; Zhang M; Chen B; Xia R
Front Immunol; 2023; 14():1191033. PubMed ID: 37426647
[TBL] [Abstract] [Full Text] [Related]
2. Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of cdx2 and IDH1/2 mutations.
Yasuda T; Sanada M; Kawazu M; Kojima S; Tsuzuki S; Ueno H; Iwamoto E; Iijima-Yamashita Y; Yamada T; Kanamori T; Nishimura R; Kuwatsuka Y; Takada S; Tanaka M; Ota S; Dobashi N; Yamazaki E; Hirose A; Murayama T; Sumi M; Sato S; Tange N; Nakamura Y; Katsuoka Y; Sakaida E; Kawamata T; Iida H; Shiraishi Y; Nannya Y; Ogawa S; Taniwaki M; Asou N; Hatta Y; Kiyoi H; Matsumura I; Horibe K; Mano H; Naoe T; Miyazaki Y; Hayakawa F
Blood; 2022 Mar; 139(12):1850-1862. PubMed ID: 34695176
[TBL] [Abstract] [Full Text] [Related]
3. The clinical significance of cdx2 in leukemia: A new perspective for leukemia research.
Darvishi M; Mashati P; Khosravi A
Leuk Res; 2018 Sep; 72():45-51. PubMed ID: 30096576
[TBL] [Abstract] [Full Text] [Related]
4. Risk factors and a prognostic score for survival after autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma.
Bröckelmann PJ; Müller H; Casasnovas O; Hutchings M; von Tresckow B; Jürgens M; McCall SJ; Morschhauser F; Fuchs M; Borchmann P; Moskowitz CH; Engert A
Ann Oncol; 2017 Jun; 28(6):1352-1358. PubMed ID: 28327958
[TBL] [Abstract] [Full Text] [Related]
5. Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry.
Trinh A; Trumpi K; De Sousa E Melo F; Wang X; de Jong JH; Fessler E; Kuppen PJ; Reimers MS; Swets M; Koopman M; Nagtegaal ID; Jansen M; Hooijer GK; Offerhaus GJ; Kranenburg O; Punt CJ; Medema JP; Markowetz F; Vermeulen L
Clin Cancer Res; 2017 Jan; 23(2):387-398. PubMed ID: 27459899
[TBL] [Abstract] [Full Text] [Related]
6. Expression of Sirt1 and FoxP3 in classical Hodgkin lymphoma and tumor infiltrating lymphocytes: Implications for immune dysregulation, prognosis and potential therapeutic targeting.
Quesada AE; Assylbekova B; Jabcuga CE; Zhang R; Covinsky M; Rios A; Nguyen ND; Brown RE
Int J Clin Exp Pathol; 2015; 8(10):13241-8. PubMed ID: 26722524
[TBL] [Abstract] [Full Text] [Related]
7. [Expression and clinical significance of caudal type homeobox transcription factor-2 in adult acute lymphocytic leukemia].
Lu HY; Xia HL; Chen XW; Zhu LX; Wang QY; Cheng X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):298-302. PubMed ID: 21518475
[TBL] [Abstract] [Full Text] [Related]
8. HOX gene expression in phenotypic and genotypic subgroups and low HOXA gene expression as an adverse prognostic factor in pediatric ALL.
Starkova J; Zamostna B; Mejstrikova E; Krejci R; Drabkin HA; Trka J
Pediatr Blood Cancer; 2010 Dec; 55(6):1072-82. PubMed ID: 20672366
[TBL] [Abstract] [Full Text] [Related]
9. Aberrant expression of the homeobox gene cdx2 in pediatric acute lymphoblastic leukemia.
Riedt T; Ebinger M; Salih HR; Tomiuk J; Handgretinger R; Kanz L; Grünebach F; Lengerke C
Blood; 2009 Apr; 113(17):4049-51. PubMed ID: 19218548
[TBL] [Abstract] [Full Text] [Related]
10. The homeobox gene cdx2 is aberrantly expressed and associated with an inferior prognosis in patients with acute lymphoblastic leukemia.
Thoene S; Rawat VP; Heilmeier B; Hoster E; Metzeler KH; Herold T; Hiddemann W; Gökbuget N; Hoelzer D; Bohlander SK; Feuring-Buske M; Buske C
Leukemia; 2009 Apr; 23(4):649-55. PubMed ID: 19158837
[TBL] [Abstract] [Full Text] [Related]
11. Expression of Galectin-3, CD138, p16INK4a, and TTF-1 in mucinous bronchioloalveolar adenocarcinoma after Hodgkin lymphoma.
Al-Salam S; Al-Ashari M
Appl Immunohistochem Mol Morphol; 2009 Jul; 17(4):351-6. PubMed ID: 18997617
[TBL] [Abstract] [Full Text] [Related]
12. Intensive chemotherapy in the treatment of aggressive diffuse large B-cell lymphoma: malignant lymphoma.
Avilés A; Nambo MJ; Neri N; Talavera A; Castañeda C; Murillo E; Cleto S; Huerta-Guzmán J
Med Oncol; 2004; 21(3):269-72. PubMed ID: 15456955
[TBL] [Abstract] [Full Text] [Related]
